SURVIVAL AND TOXICITY ASSOCIATED WITH DOCETAXEL DOSE AND SCHEDULE FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC): SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

被引：0
|
作者：
Hess, L. M. [1 ]
Oton, A. B. [1 ]
Treat, J. [1 ]
Saxman, S. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.144
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN20
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [1] The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature
    J P Sculier
    L Ghisdal
    T Berghmans
    F Branle
    J J Lafitte
    F Vallot
    A P Meert
    F Lemaitre
    E Steels
    A Burniat
    C Mascaux
    M Paesmans
    [J]. British Journal of Cancer, 2001, 84 : 1150 - 1155
  • [2] Gefitinib and docetaxel for the treatment of non-small cell lung cancer: a meta-analysis
    Yu, Huiqing
    Zhang, Aihong
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 21057 - 21065
  • [3] Effectiveness and Safety of Pemetrexed Versus Docetaxel as a Treatment for Advanced Non-small Cell Lung Cancer: a Systematic Review and Meta-analysis
    Di, Bao-Shan
    Wei, Kong-Ping
    Tian, Jin-Hui
    Xiao, Xiao-Juan
    Li, Yan
    Zhang, Xu-Hui
    Yu, Qin
    Yang, Ke-Hu
    Ge, Long
    Huang, Wen-Hui
    Zhang, Fang-Wa
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (08) : 3419 - 3424
  • [4] Treatment beyond progression in non-small cell lung cancer: A systematic review and meta-analysis
    Kuo, Wei-Ke
    Weng, Ching-Fu
    Lien, Yin-Ju
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Antibiotic treatment and survival in non-small cell lung cancer patients receiving immunotherapy: a systematic review and meta-analysis
    Abdelhamid, Arwa
    Tuminello, Stephanie
    Ivic-Pavlicic, Tara
    Flores, Raja
    Taioli, Emanuela
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (12) : 2427 - 2439
  • [6] Pathological response in resectable non-small cell lung cancer: a systematic literature review and meta-analysis
    Waser, Nathalie A.
    Quintana, Melanie
    Schweikert, Bernd
    Chaft, Jamie E.
    Berry, Lindsay
    Adam, Ahmed
    Vo, Lien
    Penrod, John R.
    Fiore, Joseph
    Berry, Donald A.
    Goring, Sarah
    [J]. JNCI CANCER SPECTRUM, 2024, 8 (03)
  • [7] Anlotinib as treatment for advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival and progression free survival
    Susanto, B.
    Marcella, E.
    Chen, S.
    Heriyanto, R. S.
    Tandiono, J.
    Wijovi, F.
    Tancherla, A.
    Kurniawan, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S792 - S792
  • [8] Meta-Analysis of Atezolizumab vs Docetaxel in Non-Small Cell Lung Cancer Treatment Outcomes
    Fu, Yingya
    Xue, Guojuan
    [J]. ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (06) : 128 - 133
  • [9] The role of mitomycin in the treatment of non small cell lung cancer: a systematic review with meta-analysis of the literature
    Sculier, JP
    Ghisdal, L
    Berghmans, T
    Branle, F
    Lafitte, JJ
    Vallot, F
    Meert, AP
    Lemaitre, F
    Steels, E
    Burniat, A
    Mascaux, C
    Paesmans, M
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (09) : 1150 - 1155
  • [10] INDIRECT COST IN NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW
    Schmidt, E.
    Stanisic, S.
    Neumann, M.
    Walzer, S.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A271 - A271
12345